Belarus vs South Korea: Previously treated cases tested for RR-/MDR-TB
Belarus
100.0%
in 2024
South Korea
100.0%
in 2024
Belarus rank
1st
South Korea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Belarus
- South Korea
How they compare
Belarus currently reports 100.0% against 100.0% in South Korea, a difference of 0.0%.
The two have swapped places 1 time across 13 shared years of data; in 2011 it was Belarus ahead.
Belarus ranks 1st and South Korea ranks 1st of 180 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.4% | 55.5% | 34.9% | Belarus |
| 2020s | 100.0% | 92.0% | 8.0% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belarus or South Korea?
- Belarus, at 100.0% against 100.0% in South Korea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belarus and South Korea?
- 0.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and South Korea?
- 13 years are reported by both, from 2011 to 2024.
- How do Belarus and South Korea rank globally for previously treated cases tested for rr-/mdr-tb?
- Belarus ranks 1st and South Korea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.